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     The effect on myocardial protection against ischemic damage by addition of the Ca 
antagonist perdipine (nicardipine) at 0.25mg/L, and 0.5mg/L, to cardioplegic solution on 
isolated rat heart was assessed by hemodynamic studies, the time required to achieve 
resuscitation, CPK assay, and histologic evaluation. 
     Twenty seven rat heart were divided into three groups of nine, with two experimental 
groups receiving different amounts of perdipine in the cardioplegic solution and group 
serving as control. Group 1 hearts (our control group) received glucose potassium cardioplegic 
solution (G. K. K ; 40mEq/L) Group 2 received nicardipine 0.25mg/L in addition to the 
standerd G. K. solution (G. P. K. 0.25). In the third group, the nicardipine dosage 
was increased to 0.5mg/L (Group 3; G. P. K. 0.5). 
     Our results indicate that the addition of perdipine to cardioplegic solution provides 
significant protection against myocardial injury during ischemic arrest. 
     The effect of perdipine (nicardipine) on hemodynamics was greatest in Group 2, 
although, Group 3 also demonstrated significant improvement with regard to several para-
meters. 
     There were statistically significant differences between the control group (Group 1) 
and the experimental groups (2 and 3) with respect to Coronary Flow (CF p<0.01), Cardiac 
Output (CO p<0.05), and the time requiered to achieve resuscitation (p<0.01). Ad-
ditionally, Groups 1 and 2 differed significantly with respect to Peak Systolic Pressure 
(PSP p<0.05) and Pressure Rate Product (PRP p<0.05). There were no significant 
differences between Groups 2 and 3. CPK levels were assayed in the three groups, with 
the average level of CPK in the coronary effluent increasing in the following order: Group 
3< 2< 1, with the difference in levels being statistically significant betwee Groups 1 and 
3 (p<0.05). Histological damage to the myocardium was mild; however, significant dif-
ferences in the appearance of contraction bands in the walls of the septum and left ventricle 
were noted between the control group (1) versus the experimental groups (2 and 3) with 
p<0.05.
河部　英明
     There were no significant differences in the appearance of the coronary arteries in 
histologic findings, though there was a significant decrease in CF following resuscitation 
from ischemic arrest in Group 1. It is conceivable that coronary vasospasm may cause 
lower CF with resultant ischemia and that Ca antagonist combined with cardioplegic solution 
may diminish post resuscitation vasospasm, thus diminishing ischemic injury. In conclusion, 
an addition of perdipine (nicardipine) to cardioplegic solution may protect the myocardium 
from ischemic damage.
                   INTRODUCTION 
      In cardiac surgery, in addition to recent advances in surgical repaire of complex 
congenital anomallies, and multiple valvular diseases, as well as cardiac transplantation, 
there are additional indications for surgery in patients over age 60 which require prolonged 
aortic clamp time and are therefore at high risk for intraoperative ischemia. There have 
been many innovations aimed at deminishing the damage sustained by the myocardium 
during the period of aortic clamping, these include topical cooling') and modifications in 
the cardioplegic solutions. Topical cooling was first introduced by SHUMMWAY2) in 1959 
and Cardioplegia using hyperkalemic solution was devised by MERLOSE" in 1955. Car-
dioplegic solutions are generally composed of 20 to 40mEq/L of potassium in the U . S . A . , 
while Mg is utilized in place of potassium in Europe. The efficacy of cardioplegia in 
protecting the myocardium is now clear, and greater than three hours duration of aortic 
clamp has become clinically feasible and safe. Since ZIMMERMAN4) (1967) theorized a 
phenomenon of calcium paradox, attention has been paid to the possibility that the use of 
Ca antagonists may protect the myocardium from ischemic damage. In this regard, fa-
vorable effects of nifedipine were reported by MAGOVERNS) and CLARK')''), and the 
efficacy and optimal concentrations of verapamil, nifedipine, and diltiazem were demon-
strated by perfusion studys on rat heart pre parations8)9~. The current study was under-
taken to provide a through evaluation of a new effectiveness of a Ca-channel blocker in 
protecting the myocardium from ischemic damage by utilizing perdipine (nicardipine ; 
Fig. 1) at two concentrations.
Fig. 1. Molecular structure of Nicardipine (YC-93)
                    MATERIAL 
     Twenty seven male rats (225-330g body weight) of the Wister Strain were used in 
this study. 
    ISOLATED WORKING HEART APPARATUS (I.W.H.A.)1o)-14) Fig. 2, Fig. 
3, as first devised by NEELY in 1967, is composed of both a retrograde LANGENDORFF 
aortic perfusion system, and an antegrade working heart made perfusion system. The 
apparatus was maintained at 37°C using the thermostat (Modular Bath Linear Cool, CR101, 
N. R. K .) . LANGENDORFF resorvoir was connected to a perfusate oxygenator and main-
tained at 75cm above the heart using a constant head device. While the heart is in 
working mode, perfusate circulates, passing from oxygenating chamber, through filter (24 
N . R. K .) to the left atrium by use of a peristaltic pump (HR FLOW INDUCER-WAT-
SON, MARLOW) and returns to the oxygenating chamber via the left ventricle, aortic
Fig. 2. Perfusion apparatus and experimental model in this study
Fig. 3. Characteristic one way valve and side arms of perfusion system
pressure chamber and aortic bubble trap in sequential order. The apparatus is equipped 
with side arm one way valve (ball valve), enabling it to increase coronary flow during all 
phases of the cardiac cycle. Pressure and heart rate were monitered by pressure chamber 
tranceducer (GOULD POLYGRAPH 141-6, SAN-EI) Effluent from heart chamber and 
aortic bubble trap were collected at various intervals and used to determine coronary flow 
and aortic flow. PEAK SYSTOLIC PRESSURE (PSP mmHg), HEART RATE (HR/ 
min), PRESSURE RATE PRODUCT (PRP), CORONARY FLOW (CF ml/min), AOR-
TIC FLOW (AF ml/min), CARDIAC OUTPUT (CO ml/min), and STROKE VOLUME 
(SV 10-1 ml/min) were measured from the above data. 
    MODIFIED KREBS-HENSELEIT BICARBONATE BUFFER (K.H.B.) (Table 1) 
was used in this experiment as the perfusate, solute concentrations pH and gas analysis 
are listed in Table 1. 
    CARDIOPLEGIC SOLUTIONS ; 
The three cardioplegic solutions used in this study (Table 2) consist of: Group 1-(G. K)-
containing 5% glucose 500ml, KC1 (40mEq in 20ml) 10ml, NaHCO3 (7w/v%) 5ml ; Group 
2-(G.P.K. 0.25)- with 0.25mg/L of nicardipine (perdipine, YAMANOUCHI Co.) add-
ed to G. K. solution ; and Group 3-(G. P. K. 0.5)- with 0.5mg/L of nicardipine added to 
G.K.
Table 1. Composition of Modified-Krebs-Henseleit Bicarbonate Buffer used 
         in this study as perfusate showing pH and gas analysis.
1. Glucose 11.0mM 
2. NaCI 118.0 PH 7.38±0.01 
3. KCI 4.7 Pco2 33.2 t 2.8 
4. CaC12-2H20 2.0 P02 567.3 ±33.6 
5. MgS04-7H20 1.2 HCO - 19.3 ± 1.3 
6. KH2PO4 1.2 B.E.3 -3.7 ± 0.9 
7. EDTA 0.5 
8. NaHCO3 2.5 
9. Distilled H20 1000ml
Table 2. The composition of the three cardioplegic solutions used in this 
          experiment.
       Group 1 Group 2 Group 3 
       GK GPKO.25 GPKO.5
5%GLUCOSE 500m1 5%GLUCOSE 500ml 5%GLUCOSE 500m1 
 HEPARIN lml HEPARIN lml HEPARIN lml 
KCI(20m1,4OmEq) 10ml KCI 10m1 KCI 10ml 
NaHC03(7W/v%) 5ml NaHCO3 5ml NaHCO3 5m1 
                        N icardipine 0 .125mN icardipine 0.25mg                       (Perdipine) g (Perdip ne)
                     METHODS 
     Wister strain rats were anesthetized with eter and a vertical midline incision was 
made to expose the abdominal and thoracic cavities. Next, 1 ml of heparin was admin-
istered via the femoral vein or vena cava, and the heart was removed by making a single 
cut through the left atrium, severing the pulmonary veins and other vessels arising from 
the heart, which was placed into cold K.H.B.-solution causing arrest within seconds. 
The aorta was then cannulated followed by five minutes of LANGENDORFF perfusion 
(with resumption of spontaneous cardiac contraction within 10 seconds) during which 
time a left atrial cannula was introduced through the pulmonary vein. Thereafter, the 
retrograde LANGENDORFF perfusion system was clamped and the working heart prep-
aration was run continuously for 10 minutes at a preload of 10cmH2O and an afterload of 
75cmH20. At this time, hemodynamic parameters such as PSP, HR, CF, AF were 
along with a one minutes collection of effluent for CPK analysis in order to establish 
baseline values. Next, 5ml of cardioplegic solutions, which were previously described for 
Groups 1, 2, 3 were administered over a one minute period by gravitational flow from a 
height of 60cm above the heart via the retrograde LANGENDORFF perfusion system, with 
cardiac arrest occuring within seconds of initiation of flow. The retrograde perfusion
Table 3. Hemodynamic parameters and heart weight in the three groups immediately prior to 
         exposure to cardioplgegic solution P.S.P. (Peak Systolic Pressure), H.R. (Heart
         Rate), C. F. (coronary Flow), A. F. (Aortic Flow), C. O. (Cardiac Output).
                          WEIGHT P.S.P. H.R. C. F. A.F. C. O. 
                    (HEART) g mmHg /min ml/min ml/min ml/min
Group 1: GK n=9 288±32 99..1± 7.3 189±27 9.9±1.0 24.0±5.7 33.9±6.2                      (1
.39±0.17) 
Group 2: GPK0.25 n=9 272±34 93.4±13.5 201±45 10.2±1.4 23.1±6.7 33.3±7.2                     (1
.38±0.17) 
Group 3: GPK0.5 n=9 296±28 91.0± 8.3 202±15 11.0±1.3 22.9±3.0 34.9±3.9                      (1 .44±0.11)
Fig. 4. Experimental Time Coarse in this study
Pictures. The appearance of contraction bands in the wall of septum and left ventricle. 
           1) Grade I.; abscence of contraction bands. 
           2) Grade 2. ; scattered contraction bands.
           3) Grade 3. ; extensive presence of contraction bands.
was clamped and the heart maintained in ischemic arrest for to 30 minutes, while in the 
heart chamber with perfusate circulating at 37°C. 
      Next the heart was resuscitated by the LANGENDORFF perfusion system and re-
sumed beating within 90 seconds. The retrograde perfusion was continued for a total of 
ten minutes to washout all cardioplegic residua. At the conclusion of this ten minute 
period the retrograde LANGENDORFF system was clamped and the working heart pre-
paration resumed. At set time intervals of 5 , 10, 15, 20, 30, 40min, the hemodynamic 
parameters stated above were once again measured (Fig. 4 ). CPK levels in coronary ef-
fluent were measured with use of Clearnizer (Nihondenshi, Co.) at three times during 
the experiment ; 1) just prior to induction of ischemic arrest with exposure to cardioplegic 
solution, (as previously described) 2) at the time of resuscitation with LANGENDORFF 
preparation, the effluent was pooled over this entire ten minute period and expressed as 
CPK total, and 3) after twenty minutes of working heart preparation following ischemic 
arrest, a one minute collection of effluent was obtained and the CPK level determined. 
Through the experiment, coronary effluent was excluded from recirculation. At the con-
clusion of the experiment, each heart was weighed by METTLER AE 100 ballance, fixed in 
10% formalin, and transversely sectioned so as to include the interventricular septum and 
the left ventricular wall. Each section was stained with hematoxylin and eosin in addition 
to the use of AZAN MARORY, PTHA and WEIGERT stain methods. Damage to the 
heart muscles was expressed by an appearance of contraction bands which were graded 
as follows ; Grade 1-abscence of contraction bands, Grade 2-scattered contraction bands 
and Grade 3-extensive presence of contraction bands as shown in Pictures 1. 2. and 3. 
      Hemodynamic data were expressed as mean values ±S. D. and as percent of con-
trols. F analysis and Student t-test were used for statistical analysis. P values less than 
0.05 were considered to be significant. Statistical significance of CPK values was esti-
mated by MANN-WHITNEY U-test (non-parametric method) with P values of less than 
0.05 and the significance of the different grades of structural alteration of the myocar-
dium was estimated by test of contingency table with P-values of less than 0.05. 
                     RESULTS 
     Hemodynamic changes during experiments in Group 1 , 2 , and 3 are represented 
in Fig. 5 a), b). and c) respectively. 
    PRE-ARREST 10 MIN OF WORKING HEART PREPARATION ; During 10 min 
of the working heart mode hemodynamic parameters of PSP, HR, CF, AF and CO were 
measured, serving as baseline value for the experiment (see Table 3) . The ratio of CF 
to CO in this phase of the experiment was approximately 1 :3.3, which was consistent 
with the NEELY8)9) report. 
     RESUSCITATION TIME; All hearts used in this study were resuscitated within 
the first 90 seconds of a 10 minute LANGENDORFF perfusion after 30 min of ischemic
Fig. 5. Hemodynamic changes in the three different time coarses among Group I 
        (G.K') a); Group 2 (G.P.K. 0.25) b); Group 3 (G.P.K. 0.5) c).
arrest. In Groups 1 and 3 , one out of the nine isolated hearts in which ischemic car-
diac arrest was induced, returned to a normal rhythm after an intervening episode of 
ventricullar fibrillation for 90 and 45 sec, respectively. The remaining hearts began to 
beat spontaneously without intervening VF. The required resuscitation times during the 
10 min LANGENDORFF perfusion in Group 1 was statistically longer than those in
Table 4. Period of time elapsed prior to cardiac resuscitation during a 10 
         minute Langendorff perfusion in the three groups.
0; heart resumed spontaneous contraction after of asystole 
0; heart resumed beating after period of ventricular fibrilation 
**; statistically significant p<0 .01
Groups 2 and 3 (P<0.01) as indicated in Table 4 . 
  POST ARREST 10 MINUTES RETROGRADE LANGENDORFF PREPARATION ; 
A comparison of coronary effluent volume to heart weight was made among the three 
groups in a 10 minutes LANGENDORFF preparation, as this is known to be directly 
related to the degree of coronary artery distension, there was no statistical significance as 
shown in Table 5 . 
    PEAK SYSTOLIC PRESSURE (PSP) ; All three Groups approached approximate 
baseline values, demonstrating variable succes, with 1 < 3 < 2 , the difference between 
Groups 1 and 2 being statistically significant (p<0.05) Table 6 and Fig. 6 . 
     HEART RATE (HR) ; Heart rate inhibitory effects of nicardipine were not ap-
parent at concentration of 0.25 or 0.5mg/L. All groups returned to baseline rates with no 
significant intergroup differences. (Fig. 6 b). 
    PRESSURE RATE PRODUCT (PRP) ; There was relative preservation of the PRP 
in the groups exposed to nicardipine Groups 2 and 3 as compared to the control, with 
significant difference (p<0.05) between groups 1 and 2 after twenty and foury mi-
nutes of the working mode. (Fig. 60. 
    CORONARY FLOW (CF) ; Values were determined begining at 5 min following 
commencement of the working heart mode (i,e ; 15 minutes post resuscitation from isc-
hemic arrest). No statistical differences were noted between the three groups at five 
minutes (Fig. 7a). A remarkable decrease in coronary flow, however, was noted in 
Group 1 by 10 min working heart mode (or 20 min post resuscitation), with a decrease
Table 5. Index of coronary artery distension as measured by the ratio of 
         perfusate volume passing through the coronary arteries versus
        heart weight in a 10 minutes Langendorff perfusion study. (ml/g)
Table 6. Hemodynamic changes with time among the three groups. (expressec 
          as a percent of their preischemic values±S.D. ,
                          5 min 10 min 15 min 20 min 30 min 40 min 
                  P.S.P. 83.2±10.4 82.7±8.2 85.9±8.8 87.5±8.3 89.1±9.1 89.419.9 
 Group 1 H. R. 95.4±22.0 97.5±24.2 100±20.5 100±18.7 106±15.5 107±15.2                   P.R.P. 77.3±16.3 80.0±19.3 85.0±15.0 86.6±11.9 93.5±10.8 94.3±9.9 
  G K C.F. 99.9±10.5 81.5±10.4 76.1±6.8 72.6±6.8 72.9±7.7 73.8±8.4                   A.F. 44.0±29.6 55.8±24.8 73.3±20.7 84.3±16.8 93.5±14.6 100±15.6 
  n=9 C.O. 61.2±21.3 64.0±17.4 74.2±14.2 80.4±11.9 87.3±10.2 92.4±12.3                   S.V. 64.4±19.6 67.5±17.4 74.2±14.2 82.5±16.9 84.6±16.5 88.4±15.6 
                  P.S.P. 88.1±9.5 90.4±8.1 92.9±9.2 97.2±10.6* 98.4±10.2 99.5±11.1
 Group 2 H.R. 93.2±23.1 97.2±23.0 100±17.4 103±11.6 104±10.6 106±8.5 
                  P.R.P. 81.8±20.8 87.7±.22.0 92.6±16.2 99.5.±9.5 * 102±10.6 10$±8.2 * 
GPK0.25 C.F. 102.±13.0 100±11.2**99.6±12.0** 100±8.9 ** 99.7±9.2 ** 101±11.3 ** 
                  A.F. 50.9±28.8 62.1±27.1 74.3±24.5 91.9±15.3 103±11.9 107±14.1 
  n=9 C.O. 68.1±17.7 74.9±17.8 82.9±16.5 93.9±9.5 * 102±8.2 ** 105±10.2 * 
                  S.V. 74.9±16.7 78.8±13.7 83.3±13.9 92.4±15.7 98.7±14.3 99.7±13.8 
                  P.S.P. 85.5±6.1 87.2±5.7 88.1±7.4 91.4±8.9 95.7±9.9 97.4±10.8 G
roup 3 H.R. 96.3±10.9 99.3±10.6 107±16.6 105±14.2 107±17.8 108±16.6 
                  P.R.P. 82.0±7.7 86.2±7.5 92.9±.8.1 95.01.7.3 101±9.1 104±9.2
GPK 0.5 C.F. 97.2±9.7 98.1±8.0** 97.8±8.8** 97.2±9.2 ** 98.3±8.7** 98.3±8.9 ** 
                  A.F. 44.5±16.6 61.3±17.3 72.1±14.6 81.1±10.1 97.5±8.8 104±6.2 
  r=9 C.O. 62.5±13.8 74.0±12.3 81.0±11.0 86.7±7.9 97.6±6.5 * 102±6.3 
                  S.V. 65.0±14.4 75.7±17.9 76.8±10.7 83.3±8.5 93.1±11.1 95.9*13.0
                **; statistically significant p-(0 .01, *; p-(0.05)
Fig. 6. Changes in hemodynamic parameter of PEAK SYSTOLIC PRESSURE 
      a) HEART RATE b), PRESSURE RATE PRODUCT c) after 30 
        minutes of ischemic arrest. (expressed as a percent of preischemic
         values ± S. D., 0-0; G. k. Group 1. •---•; G.P. K. 0.25 
         Group 2, A...... A; G.P.K. 0.5 Group 3, *; statisitcal significance
       p<0.05, **; statistical significance p-(0.01)
Fig. 7. Changs in hemodynamic parameters of CORONARY FLOW a), AORTIC 
      FLOW b), CARDIAC OUTPUT c), STROKE VOLUME d) after 30 
        minutes of ischemic arrest. (expressed as a percent of preischemic values
        ± S.D., 0-0; G. K. Group 1, •---•; G. P. K. 0.25 Group 2, 
        A...... A; G.P.K. 0.5 Group 3, *; statististical significance p<0.05,
       **; statistical significance p<0 .01)
in flow of 74%. On the other hand, the values in Groups 2 and 3 remained close to the 
initial levels. This decrease in Group 1 was maintained throughout the experiment as 
measurements at 10, 15, 20, 30 and 40 minutes of working mode revealed. The difference 
in flow at all of these time points was statistically significant (p<0.01), as compared with 
Groups 2 and 3. 
     AORTIC FLOW (AF) ; This increased among the three groups (as compared to 
baseline) at an interval of 30 to 40 min after commencement of working heart mode, 
followed by a constant flow. There was no statistical difference among the three groups 
(Fig. 7b). 
     CARDIAC OUTPUT (CO) ; This also rapidly increased after the start of perfusion. 
Statistical differences between Groups 1 and 2 were noted as (p<0.05) at 20 and 40 min 
after resumption of the working heart mode (p<0.01) at the 30 min time point. A 
difference between Groups 1 and 3 of less than 0.05 was observed after 30 min of beating 
as indicated in Fig. 7c.
     STROKE VOLUME(SV) ; The values in Groups 2 and 3 increased more than those 
in Group 1, however, there was no statistical difference among the three groups as 
illustrated in Fig. 7d. 
     ENZYME LEAKAGE (CPK) ; These values were expressed as a) the ratio of total 
CPK during a 10 min Langendorff perfusion to heart weight, b) the ratio of CPK which 
leaked 10 min to total CPK which leaked out during 1 min of the control (CPK control) 
and c) the ratio of CPK for 20 min of reworking perfusion to CPK for the control. These 
values varied with a wide range, but mean values decreased in the order ; Group 1>2>3. 
MANN-WHITNEY U-test was used for statistical analysis, and significant difference 
(p<0.05) existed between Groups 1 and 3 Fig. 7a, b, c. 
    HISTOLOGIC STRUCTURAL ALTERATIONS; Isolated hearts were examined 
histologically at completion of the experiments. Histology revealed marked edema within 
intercellular connections.
Table 7. C.P.K. leakage compared with preischemic values.
Table 8. Incidence of histologic finding of contraction band on the myocardium according 
        to its grading 
   grade of contraction Grade 1 Grade 2 Grade 3      b
and appearance 
    Group 1 n=9 0 2 1 
    Group 2 n=9 2 5 7
    Group 3 n=9 7 2 1
statistically significant p<0.05, Groups 1 and 2, Groups 1 and 3. data were analized by 
multiple sample chi-square test.
Damage to the heart. muscle was expressed by evaluation of the extent of appearance of 
contraction bands as indicated in Table 8. Group 1 had the highest incidence with 
significant differences (p<0.05) between Groups 1 and 2, and 1 and 3. 
                    DISCUSSION 
     Perfusion of the isolated heart was developed by LANGENDORFF15 in 1895, in 
which the coronary arteries were perfused via retrograde flow into the aorta.This technique 
was improved by NEELY in 1967 by addition of a "working mode" in which flow was 
antegrade through the heart via canulation of the pulmonary vein. This is not considered 
a physiologic state, as no hemoglobin is utilized and oxygen circulates in the dissolved 
form. Additionally, both pre-and after-load were fixed. Nevertheless, several features 
made this technique, a valuable for instance it allows for direct measurements of coronary 
and aortic flows in addition to analysis of metabolites released from the heart muscle, and 
the system is both simple and readily reproducible the reproducability is supported by our 
finding that the CF to CO ratio was 1:3.3, which is consistent with data reported by 
NEELY10 11> using the same system. 
     A possibility of reperfusion injury on the myocardium was proposed by ZIMMERMAN 
4) in 1967 . He proposed that Ca ion influx across the subsequent to cell membrane during 
perfusion with a calcium containing buffer, after calcium free buffer perfusion, plays an 
important role in damage to the mitchondria preceeding cell death. The myocardial 
protective effects of a Ca antagonist on preventing this "calcium paradox" were suported 
by clinical data of MAGOVERN5 and CLARK6)7'. The addition of nifedipine to cadioplegic 
solutions demonstrated to have certain advantages over traditional cardioplegic solutions in 
enhancing myocardial protection. In this regard, the effect of verapamil and nicardipine 
were recognized by SHIKANOl6)17) (1983) and YAMAMOTO8)9) (1983), who among other 
things, determined the optimal concentrations of calcium antagonists to be, 1.Opmol/L 
of verapamil, 0.075pmol/L of nifedipine and 0.50pmol/L ditiazem. These specifity concen-
trations significantly increased AF by 20, 60 and 50%, respectively, as well as reducing 
CK level by 30, 50 and 40% in LANGENDORFF resuscitating effluent that study utilized 
St. THOMAS cardioplegic solution (which contained significant levels of Ca and Mg in 
addition to solution) and other experimental model. This study demonstrated 16.3% increase 
in CO with the addition of nicardipine, with most favorable results occuring in the group 
which received 0.25mg/L of the drug. 
     CF rapidly dcreased in Group 1 by 10 min into the working heart mode. It is 
generally believed that reduction of CF after the heart has resumed beating is due to 
vasospasm of the coronary arteries. VAN NUETEN18) (1980) reported that the use of 
lidoflazin (Ca antagonist) effectively inhibits coronary vasospasm. BURTON") also noted 
that verapamil acts to completely relieve coronary vasospasm induced by KC1, as well as 
inhibiting coronary contraction induced by 5HT and angiotensin. NAKAYAMA20) reported 
the fact of transmembrane Ca ion flux into coronary artery smooth muscle cells previously
depolarized by potassium based cardioplegia. That coronary artery spasm is associated 
with Ca flux causes coronary vasospasm. KONDO et al.21), is further supported by 
demonstrated inhibition of spasm by nifedipine, diltiazem and verapamil. And LAZZETTIR 
et a122), noted that nicardipine is more effective than papaverin in inhibiting potassium 
induced coronary artery contraction. It follows from these observations that the addition 
of a Ca antagonist to potassium based cardioplegic solution may maintain coronary flow by 
inhibiting coronary spasm. 
     A furthermore, damage to the myocardium as reflected by CPK leakage was sig-
nificantly diminished in the group receiving the higher concentration of Ca antagonist. 
     Structural alterations of the myocardium were indicated by the presence of con-
traction bands. As cited by GONOTE, C. E .21), contraction bands are observed after 
reoxygenation of myocardium following hypoxic injury as well as in the setting of the "Ca 
paradox" which is observed when an isolated heart is perfused by a calcium containing 
buffer post perfusion with a Ca-free buffer. As it is hypothesized that the damage is 
secondarily increased Ca flux with resultant vasospasm, Ca antagonist may play a role in 
elimination of the calcium paradox. 
     In this study, we demonstrated that coronary vasospasm may not occur until 15 
minutes after reperfusion of ischemic hearts. Thus, a phenomenon of post ischemic dis-
tension of the coronary artery may continue to be potentiated for sometime following 
resuscitation, and that coronary vasospasm induced by transmembrane Ca ion flux into 
coronary smooth muscle cells may be delayed 15 minutes or more. Our finding therefore 
in part contradict those of YAMAMOTO et al. who indicated that post ischemic verap-
amil administration by LANGENDORFF preparation did not remarkably alter hemodynam-
ics or CK leakage in isolated heart preparations. Based upon our findings, we recom-
mend that for enhancing myocardial protection, during potassium-based cardioplegia the 
addition of a Ca antagonist is indicated. 
     Further studies of nicardipine and other Ca antagonist in conjunction with experi-
mental and clinical investigations are warranted. We believe that Ca antagonists may 
offer an important new dimension to myocardial protection in settings requiring cardio-
plegia. 
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